BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30651350)

  • 21. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.
    Thakur S; Gupta SK; Ali V; Singh P; Verma M
    Arch Pharm Res; 2021 Jul; 44(7):655-667. PubMed ID: 34279787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis.
    Petrie JL; Patman GL; Sinha I; Alexander TD; Reeves HL; Agius L
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1255-65. PubMed ID: 24045866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.
    Niimi N; Yako H; Takaku S; Chung SK; Sango K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent.
    Wong TY; Phillips AO; Witowski J; Topley N
    Kidney Int; 2003 Apr; 63(4):1404-16. PubMed ID: 12631356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
    Lorenzi M
    Exp Diabetes Res; 2007; 2007():61038. PubMed ID: 18224243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyol pathway in human epididymis and semen.
    Frenette G; Thabet M; Sullivan R
    J Androl; 2006; 27(2):233-9. PubMed ID: 16278369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-FG as substrate for investigating flux through the polyol pathway in dog lens by 19F-NMR spectroscopy.
    Lizak MJ; Secchi EF; Lee JW; Sato S; Kubo E; Akagi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2688-95. PubMed ID: 9856779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase.
    Elseweidy MM; Elesawy AE; Sobh MS; Elnagar GM
    Life Sci; 2022 Sep; 305():120751. PubMed ID: 35780841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of aldose reductase in mouse endometrial epithelial cells and its role in sperm capacitation.
    Lei Y; Nie L; Long Y; Zhao D; Liu M; Wang YC; Zhang XQ; Xu MM; Liu H; Zhang JH; Yuan DZ; Yue LM
    Theriogenology; 2023 Oct; 209():243-250. PubMed ID: 37480702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol.
    Galvez AS; Ulloa JA; Chiong M; Criollo A; Eisner V; Barros LF; Lavandero S
    J Biol Chem; 2003 Oct; 278(40):38484-94. PubMed ID: 12881532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hyperglycemia on the polyol pathway in rat kidney during the perinatal period.
    Freund N; Prieur B; Bismuth J; Delaval E
    Eur J Biochem; 1996 Nov; 242(1):86-9. PubMed ID: 8954157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyol pathway and protein kinase C activity of rat Schwannoma cells.
    Kamiya H; Nakamura J; Hamada Y; Nakashima E; Naruse K; Kato K; Yasuda Y; Hotta N
    Diabetes Metab Res Rev; 2003; 19(2):131-9. PubMed ID: 12673781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fructose and the Liver.
    Muriel P; López-Sánchez P; Ramos-Tovar E
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease.
    Wang T; Xu ZH
    Comb Chem High Throughput Screen; 2023; 26(11):1929-1944. PubMed ID: 36655533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of fructose and fructokinase in acute dehydration-induced vasopressin gene expression and secretion in mice.
    Song 宋志林 Z; Roncal-Jimenez CA; Lanaspa-Garcia MA; Oppelt SA; Kuwabara M; Jensen T; Milagres T; Andres-Hernando A; Ishimoto T; Garcia GE; Johnson G; MacLean PS; Sanchez-Lozada LG; Tolan DR; Johnson RJ
    J Neurophysiol; 2017 Feb; 117(2):646-654. PubMed ID: 27852737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of aldose reductase and the polyol pathway activity by nitric oxide.
    Srivastava SK; Ramana KV; Chandra D; Srivastava S; Bhatnagar A
    Chem Biol Interact; 2003 Feb; 143-144():333-40. PubMed ID: 12604220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.
    Lanaspa MA; Cicerchi C; Garcia G; Li N; Roncal-Jimenez CA; Rivard CJ; Hunter B; Andrés-Hernando A; Ishimoto T; Sánchez-Lozada LG; Thomas J; Hodges RS; Mant CT; Johnson RJ
    PLoS One; 2012; 7(11):e48801. PubMed ID: 23152807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Progress on Fructose Metabolism-Chrebp, Fructolysis, and Polyol Pathway.
    Iizuka K
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.